Calcified Tissue International

, Volume 53, Issue 1, pp 1–6 | Cite as

Effect of estrogen deficiency on IGF-I plasma levels: Relationship with bone mineral density in perimenopausal women

  • Elisabetta Romagnoli
  • Salvatore Minisola
  • Vincenzo Carnevale
  • Antonella Scarda
  • Rossana Rosso
  • Liliana Scarnecchia
  • Maria Teresa Pacitti
  • Gianfranco Mazzuoli
Clinical Investigations

Summary

Bone tissue is a source of growth factors; among them, insulin-like growth factor I (IGF-I) is probably an important local regulator of bone formation. This study has been carried out in order to assess the effects of natural menopause on plasma concentrations of IGF-I in the first 6 years after the cessation of gonadal function independent of age. We also examined the relationship between plasma IGF-1 levels and bone mineral density (BMD) measured at the lumbar spine (LS), at the ultradistal radius (UDR), and at the junction of the distal and middle thirds of the radius (MR). Sixty-seven healthy nonobese women, aged 45–55, were studied (premenopausal n = 21; postmenopausal n = 46, from 1 to 6 years since menopause). Plasma IGF-I levels were measured by RIA, after acid-ethanol extraction. BMD of the forearm was measured by dual-photon densitometer and BMD of the LS was assessed by quantitative digital radiography. Mean values of IGF-I plasma levels were significantly reduced in postmenopausal women compared to the premenopausal group. Menopausal duration did not influence IGF-I plasma levels in postmenopausal women. We also found a positive correlation between IGF-I levels and BMD measured at MR both in pre- and postmenopausal women, while a correlation with LS and UDR-BMD was found only in fertile subjects. The results show that IGF-I plasma levels decrease immediately after menopause, since significantly lower levels are reached in the first years. The correlations found between plasma IGF-I levels and BMD suggest a possible role of reduced IGF-I in bone loss at particular skeletal sites.

Key words

Insulinlike growth factor I Bone mineral density Natural menopause 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Raisz LG (1988) Local and systemic factors in the pathogenesis of osteoporosis. N Engl J Med 318:818–828Google Scholar
  2. 2.
    Canalis E, Mc Carthy T, Centrella M (1988) Growth factors and the regulation of bone remodeling. J Clin Invest 81:277–281Google Scholar
  3. 3.
    Sara VR, Hall K (1990) Insulin-like growth factors and their binding proteins. Physiol Rev 70:591–614Google Scholar
  4. 4.
    Canalis E, Mc Carthy T, Centrella M (1988) Isolation and characterization of insulin-like growth factor I (Somatomedin C) from cultures of fetal rat calvariae. Endocrinology 122:22–27Google Scholar
  5. 5.
    Wong GL, Kotliar D, Schlaeger D, Brandes SJ (1990) IGF-I production by mouse osteoblasts. J Bone Miner Res 5:133–140Google Scholar
  6. 6.
    Valentin-Opran A, Delmas PD, Chevassieux PM, Chenu C, Saez S, Meunier P (1986) 1,25-Dihydroxyvitamin D3 stimulates the somatomedin C secretion by human bone cells in vitro. J Bone Miner Res Suppl 1:(Abs) 139Google Scholar
  7. 7.
    Spencer EM, Liu CC, Si ECC, Howard GA (1991) In vivo actions of insulin-like growth factor I (IGF-I) on bone formation and resorption in rats. Bone 12:21–26Google Scholar
  8. 8.
    Hock JM, Centrella M, Canalis E (1988) Insulin-like growth factor-I has independent effects on bone matrix formation and cell replication. Endocrinology 122:254–260Google Scholar
  9. 9.
    Mc Carthy T, Centrella M, Canalis E (1989) Regulatory effects of insulin-like growth factors I and II on bone collagen synthesis in rat calvarial cultures. Endocrinology 124:301–309Google Scholar
  10. 10.
    Canalis E, Lian JB (1988) Effects of bone associated growth factors on DNA, collagen and osteocalcin synthesis in cultured fetal rat calvariae. Bone 9:243–246Google Scholar
  11. 11.
    Thiebaud D, Ng KW, Findlay DM, Harker M, Martin TJ (1990) Insulinlike growth factor I regulates mRNA levels of osteonectin and pro-a1 (I)-collagen in clonal preosteoblastic calvarial cells. J Bone Miner Res 5:761–767Google Scholar
  12. 12.
    Zhang RW, Simmons DJ, Crowther RS, Mohan S, Baylink DJ (1991) Contribution of marrow stromal cells to the regulation of osteoblast proliferation in rats: evidence for the involvement of insulin-like growth factors. Bone Miner 13:201–215Google Scholar
  13. 13.
    Yamamoto H, Sohmiya M, Oka N, Kato Y (1991) Effects of aging and sex on plasma insulin-like growth factor I (IGF-I) levels in normal adults. Acta Endocrinol (Copenh) 124:497–500Google Scholar
  14. 14.
    Bando H, Zhang C, Takada Y, Yamasaki R, Saito S (1991) Impaired secretion of growth-hormone-releasing hormone, growth hormone and IGF-I in elderly men. Acta Endocrinol (Copenh) 124:31–36Google Scholar
  15. 15.
    Kelijman M (1991) Age-related alterations of the growth-hormone/insulin-like growth factor I axis. J Am Geriatr Soc 39:295–307Google Scholar
  16. 16.
    Vermeulen A (1987) Nyctoemeral growth hormone profiles in young and aged men: correlation with somatomedin-C levels. J Clin Endocrinol Metab 64:884–888Google Scholar
  17. 17.
    Poehlman ET, Copeland KC (1990) Influence of physical activity on insulin-like growth factor I in healthy younger and older man. J Clin Endocrinol Metab 71:1468–1473Google Scholar
  18. 18.
    Bennett AE, Wahner HW, Riggs L, Hintz RL (1984) Insulin-like growth factors I and II: aging and bone density in women. J Clin Endocrinol Metab 59:701–704Google Scholar
  19. 19.
    Kelly PJ, Eisman JA, Stuart MC, Pocock NA, Sambrook PN, Gwinn TH (1990) Somatomedin-C, physical fitness, and bone density. J Clin Endocrinol Metab 70:718–723Google Scholar
  20. 20.
    Dawson-Hughes B, Stern D, Goldman J, Reichlin S (1986) Regulation of growth hormone and somatomedin-C secretion in postmenopausal women: effect of physiological estrogen replacement. J Clin Endocrinol Metab 63:424–432Google Scholar
  21. 21.
    Ho KY, Evans WS, Blizzard RM, Veldhuis JD, Merriam GR, Samojlik E, Furlanetto R, Rogol AD, Kaiser DL, Thorner MO (1987) Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations. J Clin Endocrinol Metab 64:51–57Google Scholar
  22. 22.
    Franchimont P, Urbain-Choffray D, Lambelin P, Fontaine MA, Frangin G, Reginster JY (1989) Effects of repetitive administration of growth hormone-releasing hormone on growth hormone secretion, insulin-like growth factor I, and bone metabolism in postmenopausal women. Acta Endocrinol (Copenh) 120:121–128Google Scholar
  23. 23.
    Weissberger AJ, Ho KKY, Lazarus L (1991) Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-h growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women. J Clin Endocrinol Metab 72:374–381Google Scholar
  24. 24.
    Bellantoni MF, Harman M, Che DE, Blackman MR (1991) Effects of progestin-opposed transdermal estrogen administration on growth hormone and insulin-like growth factor I in post-menopausal women of different ages. J Clin Endocrinol Metab 72:172–178Google Scholar
  25. 25.
    Hintz RL (1990) Role of growth hormone and insulin-like growth factor binding proteins. Horm Res 33:105–110Google Scholar
  26. 26.
    Baxter RC (1991) Physiological role of IGF binding proteins. In: Spencer EM (ed) Modern concepts of insulin-like growth factors. Elsevier, New York, pp 371–380Google Scholar
  27. 27.
    Donahue LR, Hunter SJ, Sherblom AP, Rosen C (1990) Age-related changes in serum insulin-like growth factor binding proteins in women. J Clin Endocrinol Metab 71:575–579Google Scholar
  28. 28.
    Rosen C, Donahue LR, Hunter S, Holick M, Kavookjian H, Kirschenbaum A, Mohan S, Baylink DJ (1992) The 24/25-KDa serum insulin-like growth factor-binding protein is increased in elderly women with hip and spine fractures. J Clin Endocrinol Metab 74:24–27Google Scholar
  29. 29.
    Schmid C, Ernst M, Zapf J, Froesch ER (1989) Release of insulin like growth factor carrier proteins by osteoblasts: stimulation by estradiol and growth hormone. Biochem Biophys Res Commun 160:788–794Google Scholar
  30. 30.
    Martin JL, Baxter RC (1986) Insulin-like growth factor-binding protein from human plasma. Purification and characterization. J Biol Chem 261:8754–8760Google Scholar
  31. 31.
    Wood WI, Cachianes G, Henzel WJ, Winslow GA, Spencer SA, Hellniss R, Martin JL, Baxter RC (1988) Cloning and expression of the growth hormone-dependent insulin-like growth factor-binding protein. Mol Endocrinol 2:1176–1185Google Scholar
  32. 32.
    Ernst M, Heath JK, Rodan GA (1989) Estradiol effects on proliferation, messenger ribonucleic acid for collagen and insulin-like growth factor I, and parathyroid hormone-stimulated adenylate cyclase activity in osteoblastic cells from calvariae and long bones. Endocrinology 125:825–833Google Scholar
  33. 33.
    Bouillon R (1991) Growth hormone and bone. Horm Res 36(Suppl 1):49–55Google Scholar
  34. 34.
    Diamond T, Nery L, Posen S (1989) Spinal and peripheral bone mineral densities in acromegaly: the effects of excess growth hormone and hypogonadism. Ann Intern Med 111:567–573Google Scholar
  35. 35.
    Meier DE, Orwoll ES, Jones JM (1984) Marked disparity between trabecular and cortical bone loss with age in healthy men. Ann Intern Med 101:605–612Google Scholar
  36. 36.
    Ruegsegger P, Durand EP, Dambacher MA (1991) Differential effects of aging and disease on trabecular and compact bone density of the radius. Bone 12:99–105Google Scholar
  37. 37.
    Parfitt AM (1991) Growth hormone and adult bone remodelling. Clin Endocrinol 35:467–470Google Scholar
  38. 38.
    Girasole G, Jilka RL, Passeri G, Boswell S, Boder G, Williams DC, Manolagas SC (1992) 17beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens. J Clin Invest 89:883–891Google Scholar
  39. 39.
    Pacifci R, Brown C, Puscheck E, Friedrich E, Slatopolsky E, Maggio D, Mc Cracken R, Avioli LV (1991) Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells. Proc Natl Acad Sci USA 88:5134–5138Google Scholar

Copyright information

© Springer-Verlag New York Inc. 1993

Authors and Affiliations

  • Elisabetta Romagnoli
    • 1
  • Salvatore Minisola
    • 1
  • Vincenzo Carnevale
    • 1
  • Antonella Scarda
    • 1
  • Rossana Rosso
    • 1
  • Liliana Scarnecchia
    • 1
  • Maria Teresa Pacitti
    • 1
  • Gianfranco Mazzuoli
    • 1
  1. 1.II Clinica Medica, Medicina InternaUniversità degli Studi di Roma “La Sapienza,”RomeItaly

Personalised recommendations